RCKT — Rocket Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- $2.06bn
- $1.71bn
- 48
- 20
- 67
- 41
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -77.3 | -140 | -169 | -222 | -246 |
Depreciation | |||||
Non-Cash Items | 15.9 | 48.9 | 45.9 | 31.4 | 30.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3.73 | 15 | -3.39 | 6.08 | 13.5 |
Change in Prepaid Expenses | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -64.7 | -74.6 | -121 | -178 | -195 |
Capital Expenditures | -23.3 | -29.1 | -7.71 | -8.62 | -16.5 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -15.7 | -67.5 | 26.6 | -60.7 | -81.6 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -39 | -96.6 | 18.9 | -69.3 | -98.1 |
Financing Cash Flow Items | -0.344 | -0.851 | 0 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 178 | 283 | 37.7 | 155 | 208 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 74.1 | 112 | -64.6 | -92.2 | -84.6 |